Author(s): Nikhil. S. Gawas, Meenaxi Maste, Shailendra. S. Suryawansh

Email(s): meenaximaste@klepharm.edu

DOI: 10.52711/0974-360X.2024.00229   

Address: Nikhil. S. Gawas, Meenaxi Maste*, Shailendra. S. Suryawanshi Department of Pharmaceutical Chemistry, KAHER’s KLE College of Pharmacy, Belagavi. 590010. *Corresponding Author

Published In:   Volume - 17,      Issue - 4,     Year - 2024


ABSTRACT:
Tofisopam is an anxiolytic used in treatment of anxiety like disorders, prescribed in the dosage of 50mg to 300mg. As the drug is insoluble in water it is necessary to develop an economical and streamlined liquid chromatography for determination of pure and commercial dosage of Tofisopam. The main objective of the work is to develop and validate an RP-HPLC method for determination of Tofisopam as per ICH guidelines. An RP- HPLC method was devised using 0.1% Orthophosphoric acid in water: methanol in the ration 10:90% v/v and validated for parameters such as system suitability, linearity, limit of detection, limit of quantitation, precision, accuracy, assay, robustness, and ruggedness, as per ICH Guidelines. Tofisopam showed the maximum absorbance at 238nm with good system suitability and linearity was entrenched within the range of 10-60µg/ml, with the regression coefficient of 0.9996. The limit of detection and limit of quantitation were found to be 2.75 µg/ml and 8.855µg/ml respectively. Assay was valuated to be 101%, Accuracy was valuated between 98-103%, and %RSD was less the 2% for precision, robustness and ruggedness, so the method is precise and accurate. The method robustness is demonstrated by insignificant variations in absorption values and mobile phase ratio with deliberate alterations. In accordance with the validation results, the procedure is simple, specific, precise, accurate, robust and suitable for routine analysis of Tofisopam in bulk and commercial products.


Cite this article:
Nikhil. S. Gawas, Meenaxi Maste, Shailendra. S. Suryawansh. Analytical Method Development and Validation of Tofisopam in Pure and Pharmaceutical formulation.Research Journal of Pharmacy and Technology.2024; 17(4):1449-2. doi: 10.52711/0974-360X.2024.00229

Cite(Electronic):
Nikhil. S. Gawas, Meenaxi Maste, Shailendra. S. Suryawansh. Analytical Method Development and Validation of Tofisopam in Pure and Pharmaceutical formulation.Research Journal of Pharmacy and Technology.2024; 17(4):1449-2. doi: 10.52711/0974-360X.2024.00229   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-4-3


REFERENCES:
1.    Rundfeldt C, Socała K. and Wlaź. The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. Journal Neural Transmission. 2010; 117: 1319–1325.doi: 10.1007/s00702-010-0507-3.
2.    Philippe C, Antoine S, Jean-P C, Mike. Indirect dopaminergic effects of tofisopam, a 2,3-benzodiazepine, and their inhibition by lithium. Journal of Pharmacy and Pharmacology. 1985; 37(12): 917-19.doi: 10.1111/j.2042-7158.1985.tb05003.x
3.    Nesrin K R, Afaf O, Roaida F, Azza A M. Development and validation of spectrophotometric and spectrofluorimetric methods for simultaneous determination of Tofisopam. Journal of Applied Pharmaceutical Science. 2012; 2(3): 112-19.
4.    Amer A, Mohammed A, Haitham R, Gamal A H M. Development of two charge-transfer complex spectrophotometric methods for determination of tofisopam in tablet dosage form. Tropical Journal of Pharmaceutical Research. 2016; 15(5): 995-1001. doi10.4314/tjpr.v15i5.14.
5.    Kokane M, Pananchery J, Jain A. Development and validation of spectrophotometric method for determination of tofisopam in bulk and pharmaceutical formulation. Pharmaceutica Analytica Act. 2017; 8(6): 1-4. doi 10.4172/2153-2435.1000551.
6.    Eiichi M, Tomomi G, Tsutomu O, Hisao O, Hisayuki K. Simultaneous analysis of seven benzodiazepines in dietary supplements as adulterants using high performance liquid chromatography and its applications to an identification system for Diazepam. Journal of Health Science. 2005; 51(3): 278-83. doi10.1248/jhs.51.278.
7.    Mougang H, Ping H, Yong C, Geoff C, Junan G, NaidongY. Method validation and determination of enantiomers and conformers in tofisopam drug substances and drug products by chiral high-performance liquid chromatography and kinetic and thermodynamic study of the interconversion of the conformers. Journal of Chromatography A. 2006; 1129(1): 47-53. doi10.1016/j.chroma.2006.06.085
8.    Shantkriti S, Rosemary T,Parameswara Rao K, M. C. Rao. Validation of stability indicating RP-HPLC assay method oftofisopam in pharmaceutical dosage from. Research Journal of Pharmaceutical Biological and Chemical Sciences. 2017; 8(2): 841-47.
9.    Dukhovskaya N, Yanushevich O, Vavilova T, Gremyakova P, Ostrovskaya I.Method for Quantitative Determination of Phenazepamin mixed saliva. Georgian Medical News. 2019; 287: 132-37.PMID 30958305.
10.    Manzoor A, Ameern K, A. Satish K S, G. Narayana M. Development and validation of tofisopam by RP-HPLC method in bulk and pharmaceutical dosage forms. World Journal of Pharmacy amd Pharmaceutical Science. 2018; 7(5): 1066-71. doi 10.20959/wjpps20185-11518.
11.    Foroughbakhshfasaei, M, ZI Szabo, Arash M, Peter H,Gergi T. Enantiomeric quality control of R-Tofisopam by HPLC using polysaccharide-type chiral stationary phases in polar organic mode. Electrophoresis. 2018 Jul 12; 39(20):2566-74.doi 10.1002/elps.201800220.
12.    Megha K, Jeeja P, Monika J, Ashish J. Analytical QbD approach for development and validation of RP-High performance liquid chromatography method for determination of tofisopam in pure form and tables. International Journal of Pharmaceutical Sciences and Drug Research. 2020 Mar 30;12(2):159-65.doi 10.25004/IJPSDR.2020.120210.
13.    Mohan S, Satyanarayana P, Nagalakshmi V, Sudheer K K, Srinivasa R G. Development and Validation of RP-HPLC Method for the Estimation of L-Methyl Folate and Tofisopam in combined Formulation. Asian Journal of Research in Chemistry. 2021;14(1):28-36.doi 10.5958/0974-4150.2021.00005.5.
14.    Miklos P, Janos S. High-performance liquid chromatographic determination of grandaxin (a 2,3-benzodiazepine) and its trace impurities. Journal of Chromatography. 1981;210:159-162.doi 10.1016/S0021-9673(00)91194-4.
15.    Moore C M, Sato K, Katsumata Y. Rapid monitoring of Benzodiazepines in clinical samples b using on-line column switching HPLC. Clinical Chemistry. 1991 Jun 01;37(6):804-8.doi 10.1093/clinchem/37.6.804.
16.    Guillaume Y, Guinchard C. Study and optimization of column efficiency in HPLC: Comparison of two methods for separating ten Benzodiazepines. Journal of liquid chromatography. 1994 Dec 01;17(7):1443-59.
17.    Sajgo M, Gesztesi A, Sido T. Determination of tofisopam in serum by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 1981 Feb 13;222(2):303-07.doi 10.1016/S0378-4347(00)81065-8.
18.    Soo K B, Sung J C, Jeong S K, Eun J P, Dong H S, Hee-Yong L, Hye S L. Analysis of tofisopam in human serum by column-switching semi-micro high-performance liquid chromatography and evaluation of tofisopambioquivalency. Biomedical Chromatography. 2002 Mar 20;16(4):277-81.doi 10.1002/bmc.142.
19.    Satyanarayana L, Naidu S V, Narasimha Rao M, Alok M, Suresh K. The estimation of Darunavir in tablet dosage form by RP-HPLC. Research Journal of Pharmacy and Technology. 2011 Aug 08;1(3):74-76.
20.    Janaki P, Appala Raju N. The Estimation of Epalrestat in Tablet Dosage Form by RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2012 Apr-Jun;2(2):49-51.
21.    Sharmin RC, Mahfuza M, Mahbubul H S. Development and Validation of a Simple RP-HPLC Method for Determination of Caffeine in Pharmaceutical Dosage Forms. Asian Journal of Pharmaceutical Analysis. 2012 Jan-Mar;(1):01-04.
22.    Vijaya Sri K,Anusha M, Ravinder S R. A Rapid RP-HPLC Method development and Validation for the Analysis of Linagliptinin Bulk and Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Analysis. 2015 Mar 02;5(1):16-20.doi 10.5958/2231-5675.2015.00003.4.
23.    Samson I D, Shiny G,Vinay Kumar B. A Rapid RP HPLC Method Development and Validation for the Analysis of Divalproinex in Bulk and Pharmaceutical Dosage Forms. Asian Journal of Pharmaceutical Analysis. 2016 Apr 2;6(1):15-22.doi 10.5958/2231-5675.2016.00003.X.
24.    Sushil D. P, Sunil V. A, Upasani C D. Development and Validation of Stability Indicating RP-HPLC Method for Empagliflozin. Asian Journal of Pharmaceutical Analysis. 2017 Feb 02;6(4):201-06.doi 10.5958/2231-5675.2016.00030.2.
25.    Sivagami B, Nagendramma D, Chandrasekar R, Niranjan babu M. RP-HPLC Method Development and Validation for the Estimation of Seratrodast in Bulk and Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Analysis. 2018 Jul;8(2):96-102.
26.    Rele R.V., Patil S.P. Reversed Phase High-Pressure Liquid Chromatography Technique for Determination of Oxolamine Citrate from Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2011 May;4(5): May 2011:787-89.
27.    Bhushan P, Ravi T. Development and Validation of an RP-HPLC Method for the Estimation of Bupropion Hydrochloride. Research Journal of Pharmacy and Technology. 2011 Sept;4(9):1480-82.
28.    Mousumi K, Sachin D. Development of RP-HPLC Method for Estimation of Citalopram Hbr. Research J. Pharm. and Tech. 2011 Dec;4(12):1807-08.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available